Back
UroGen Pharma Vs. Apogee Enterprises Industry Stock Comparison
Sell
23
URGN
UroGen Pharma
Last Price:
$11.02
Seasonality Move:
-4.35%
Sell
31
APOG
Apogee Enterprises
Last Price:
$52.54
Seasonality Move:
6.47%
Sell
23
UroGen Pharma (URGN)
is a Sell
Is UroGen Pharma a Buy, Sell or Hold?
-
The current UroGen Pharma [URGN] share price is $11.08. The Score for URGN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Apogee Enterprises (APOG)
is a Sell
Is Apogee Enterprises a Buy, Sell or Hold?
-
The current Apogee Enterprises [APOG] share price is $57.60. The Score for APOG is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
APOG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URGN Stock Price Chart
What is UroGen Pharma's stock price today?
-
The UroGen Pharma share price today is $11.08Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing selling pressure, which indicates risk of future bearish movement.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $57.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing selling pressure, which indicates risk of future bearish movement.
URGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 46.24 | Sell |
Chaikin Money Flow: | -240892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.68 - 12.04) | Sell |
Bollinger Bands (100): | (11.4 - 13.64) | Sell |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.47 | Sell |
Relative Strength Index (14 RSI): | 14.17 | Sell |
Chaikin Money Flow: | -873322 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (69.35 - 81.43) | Sell |
Bollinger Bands (100): | (66.37 - 81.29) | Sell |
URGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.87 | Buy |
20-day SMA: | 11.09 | Sell |
50-day SMA: | 11.73 | Sell |
200-day SMA: | 13.68 | Sell |
8-day EMA: | 10.95 | Buy |
20-day EMA: | 11.14 | Sell |
50-day EMA: | 11.69 | Sell |
200-day EMA: | 13.21 | Sell |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.01 | Sell |
20-day SMA: | 73.32 | Sell |
50-day SMA: | 78.37 | Sell |
200-day SMA: | 68.03 | Sell |
8-day EMA: | 68.74 | Sell |
20-day EMA: | 72.68 | Sell |
50-day EMA: | 75.36 | Sell |
200-day EMA: | 68.66 | Sell |
UroGen Pharma Earnings Growth & URGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $2.30 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.04 per share, an increase this year of $0.43 per share, and a decrease next year of $0.07 per share.
UroGen Pharma Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |